Day 1 - Wednesday, 7 October 2020
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
Related Enduring Materials
DAY 2 - Thursday, 8 October
What's New
- A summary of the Fourth Annual HIV Microbiome Workshop by Dr. Brett Williams (Rush University Medical Center) has been published on the AIDS Research and Human Retroviruses journal (Vol.36, No. 5, May 2020).
- To stay updated on developments in relation to the workshop, make sure you are signed up for our newsletter.
Welcome
The 6th International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment took place on the 7th and 8th October 2020.
The understanding of the human microbiome continues to grow rapidly. However information on the role of the microbiome on HIV infection pathogenesis, prevention, and treatment is still limited. Whereas research in this area may be presented at major conferences, there are often limited sessions devoted to this topic as well as limited time for in-depth discussion and debate among cross-disciplinary experts on new data and their implications. The aim of this workshop is to provide increased opportunities for discussion and exchange of knowledge following formal presentation of the latest research.
The multidisciplinary nature and the significance in furthering our ability to develop novel prevention and therapeutic strategies for HIV will lead to the reduction of new HIV infections and the burden of non-communicable diseases in individuals living with HIV. We also will be able to learn how the host microbiome can influence responses to our current HIV therapies.
This 2-day workshop had invited lectures by key opinion leaders, oral abstract presentations, and poster presentations. Ample time was allocated for discussion in an intimate workshop setting. The workshop was unique in its approach, as it engaged basic scientists and clinicians from the HIV field and leading scientists involved in microbiome research including bioinformatics experts.
Clinicians and researchers with an interest in Microbiome in HIV Pathogenesis, Prevention and Treatment were invited to attend this workshop.
Chairs 2020
General Information
The virtual edition provided an immersive experience to all participants through an interactive platform for real-time Q&A sessions and round-tables to fuel inspiring discussions that will move the microbiome and HIV interaction field forward.
We are available to answer any questions or concerns that you may have about your participation at this new format of the Workshop on Microbiome in HIV 2020. For more information, please contact Federica.Ressa@amededu.com
To stay updated on developments in relation to the Workshop on Microbiome, make sure you are signed up for our newsletter.
- To gather cross-disciplinary professionals in the field of microbiome research to provide a better understanding of the impact of microbiome changes on HIV outcomes
- To develop a better understanding of how the microbiome effects the pathogenesis of HIV across mucosal sites
- To enhance our knowledge of how the microbiome can impact vaccine responses
- To better understand how the microbiome can contribute to the development of non-communicable diseases
- To use our knowledge of the microbiome field in developing novel strategies for developing microbicides for HIV prevention
- To bring together scientists from across the globe to enhance our understanding of how we can use approaches to modulate the microbiome to reduce levels of inflammation
- To bring together bioinformatics experts in enhancing our ability to analyze complex data generated by sequencing the host microbiome
- To recall the complex interplay between the human microbiome, host immunity, and pathogenesis
- To translate research achievements into challenges for the development of preventive approaches to reduce virus transmission
Practical Information
No simultaneous translation was provided.
The members of the Organizing Committee (OC) discuss, on a frequent basis, the scientific program of the workshop, identify interesting topics and candidate speakers.
Scientific Committee
The members of the Scientific Committee assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.
-
Shaun Barnabas, MD - University of Cape Town, South Africa
-
Stacy Carrington-Lawrence, PhD - NIH/OAR, USA
-
Que Dang, PhD - NIAID/NIH, USA
-
Wendy Henderson, PhD, MSN, CRNP, FAAN - NINR, NIH, DHHS, USA
-
Steve Innes, MBChB, MRCPCH, MPhil, PhD - Stellenbosch University, South Africa
-
Douglas Kwon, MD, PhD - Ragon Institute of MGH, MIT and Harvard, USA
-
Angela Malaspina, PhD - NIAID/NIH, USA
-
John McGowan, PhD - NIAID, USA
-
Piotr Nowak, MD, PhD - Karolinska University Hospital, Sweden
-
Sandra Pinto Cardoso, PhD - Centre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico
-
Angela Wahl, PhD - University of North Carolina at Chapel Hill, USA
-
Cara Wilson, MD - University of Colorado, USA
In order to deliver this event, we depend on corporate support. Collaboration with the pharmaceutical industry is vital for both the organizational as well as the scientific success of the program.
For industry support opportunities please contact our managing director Mrs. Alice Posthumus-Plantinga at alice.posthumus-plantinga@amededu.com or call +31 6 2248 2179.